Overview

To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers

Status:
Not yet recruiting
Trial end date:
2021-07-20
Target enrollment:
Participant gender:
Summary
The purpose of study is to compare the safety and pharmacokinetics of PT105 with PT105R in healthy postmenopausal female volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Peptron, Inc.
Treatments:
Leuprolide